establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 6 Compare versions History 34 Sponsors 6

No summary has been published for this bill. The full text is on the Bill text tab.

Chamber: House
Introduced: Dec 18, 2025
Last action: Mar 19, 2026 — Majority Committee Report: Inexpedient to Legislate 03/17/2026 (Vote 13-11; RC)
Sponsor: Buzz Scherr D
Session: 2026
Momentum: 5 · Stalled